Status:
COMPLETED
TDF Long Term Study
Lead Sponsor:
The HIV Netherlands Australia Thailand Research Collaboration
Collaborating Sponsors:
Chulalongkorn University
Bamrasnaradura Infectious Diseases Institute
Conditions:
HIV-infected Thai Children
Eligibility:
All Genders
8-18 years
Brief Summary
This study will assess the safety and efficacy of generic TDF from Governmental Pharmaceutical Organization (GPO) in HIV-infected children
Detailed Description
TDF is a nucleotide reverse transcriptase inhibitor (NRTI) which can be taken only once per day and continues to have good efficacy even in patients who have resistance to other NNRTI in the absence o...
Eligibility Criteria
Inclusion
- children who are changing to TDF due to adherence problem or treatment failure
- children who are already on TDF due to their clinical indication
Exclusion
- child/caretaker refuse to participate in this study
- cannot adhere to the study schedule
Key Trial Info
Start Date :
December 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 1 2013
Estimated Enrollment :
36 Patients enrolled
Trial Details
Trial ID
NCT01815255
Start Date
December 1 2010
End Date
August 1 2013
Last Update
July 17 2020
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
HIV-NAT
Bangkok, Thailand, 10330
2
King Chulalongkorn Hospital, Chulalongkorn University
Bangkok, Thailand, 10330